Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Iceland - Delayed Quote • ISK Alvotech (ALVO.IC) Follow Add holdings 1,005.00 -35.00 (-3.37%) At close: April 28 at 4:24:14 PM GMT+1 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for ALVO.IC 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: ALVO.IC View More All News Press Releases SEC Filings Alvotech (NASDAQ:ALVO) Just Reported And Analysts Have Been Lifting Their Price Targets Alvotech Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer Alvotech Reports Record Results for 2024 and Provides Business Update UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab) Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production Alvotech and Dr. Reddy’s Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva® Exploring 3 High Growth Tech Stocks In The US Market Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida Alvotech to Report Full Year Financial Results for 2024 on March 26, 2025, and Hosts Conference Call on March 27, 2025, at 8:00 am ET Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S. Related Tickers EVO Evotec SE 4.3000 +1.90% GALD.SW Galderma Group N 93.30 +0.05% ZTS Zoetis Inc. 153.57 +0.07% 1795.TW Lotus Pharmaceutical Co., Ltd. 220.50 +0.46% TEVA Teva Pharmaceutical Industries Limited 15.02 +1.01% TLRY Tilray Brands, Inc. 0.4769 -2.09%